Vivax malaria in pregnancy and lactation: a long way to health equity.
Tobias BrummaierMary Ellen GilderGornpan GornsawunCindy S ChuGermana BanconeMupawjay PimanpanarakKesinee ChotivanichFrançois NostenRose McGreadyPublished in: Malaria journal (2020)
Adverse effects of vivax malaria in pregnancy, ineligibility of radical cure for pregnant and postpartum women, and difficulties in diagnosing intermediate levels of G6PD activity multiplied morbidity in this woman. Steps towards meeting the SDG include prevention of malaria in pregnancy, reducing unnecessary exclusion of women from radical cure, and accessible quantitative G6PD screening in P. vivax-endemic settings.
Keyphrases
- plasmodium falciparum
- pregnancy outcomes
- preterm birth
- pregnant women
- polycystic ovary syndrome
- healthcare
- emergency department
- high resolution
- mental health
- type diabetes
- human milk
- health information
- insulin resistance
- metabolic syndrome
- mass spectrometry
- risk assessment
- low birth weight
- preterm infants
- breast cancer risk
- health promotion